Measles serological survey in the Italian population: Interpretation of results using mixture model

Vaccine

Volumn 26, Issue 34, 2008, Pages 4403-4409

  Rota, Maria Cristina ^a   Massari, Marco ^a   Gabutti, Giovanni ^b   Guido, Marcello ^c   De Donno, Antonella ^c   Atti, Marta Luisa Ciofi degli ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c UNIVERSITY OF SALENTO   (Italy)

Author keywords

Italy; Measles; Mixture model; Seroprevalence

Indexed keywords

ADOLESCENT; ANTIBODY DETECTION; ARTICLE; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; INCIDENCE; ITALY; MEASLES; MEASLES VACCINATION; MODEL; PRIORITY JOURNAL; SEROLOGY; SEROPREVALENCE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GEOGRAPHY; HUMANS; INFANT; INFANT, NEWBORN; ITALY; MALE; MEASLES; MEASLES VACCINE; MIDDLE AGED; MODELS, STATISTICAL; SEROEPIDEMIOLOGIC STUDIES;

EID: 47649108077     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.05.094     Document Type: Article

References (24)

1. Ciofi degli Atti M.L., Fabi F., Salmaso S., Pizzuti R., de Campora E., and Pennacchio L.A. Measles epidemic attributed to inadequate vaccination coverage- Campania, Italy, 2002. MMWR Morb Mortal Wkly Rep. 52 43 (2003) 1044-1047
2. Filia A., Brenna A., Panà A., Maggio Cavallaro G., Massari M., and Ciofi degli Atti M.L. Health burden and economic impact of measles-related hospitalizations in Italy in 2002-2003. BMC Public Health 7 (2007) 169
3. Williams J.R., Manfredi P., Butler A., Ciofi Degli Atti M.L., and Salmaso S. Heterogeneity in regional notification patterns and its impact on aggregate national case notification data: the example of measles in Italy. BMC Public Health 3 (2003) 23
4. Ciofi degli Atti M.L., Rota M.C., Bella A., Salmaso S., and ICONA Study Group. Do changes in policy affect vaccine coverage levels? Results of a national study to evaluate childhood vaccination coverage and reasons for missed vaccination in Italy. Vaccine 22 (2004) 4351-4357
5. Conferenza Stato Regioni. Accordo tra Governo, Regioni e le Province Autonome di Trento e Bolzano sul Piano Nazionale per l'eliminazione del morbillo e della rosolia congenita, 2003-2007. 13 novembre 2003 (http://governo.it/backoffice/allegati/20894-1712.pdf) [accessed 04 May 2006].
6. Osborne K., Weinberg J., and Miller E. The European Sero-Epidemiology Network (ESEN). Euro Surveill 2 (1997) 29-31
7. Vyse A.J., Gay N.J., Hesketh L.M., Pebody R., Morgan-Capner P., and Miller E. Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century. Epidemiol Infect 134 6 (2006) 1303-1312
8. Gay N.J., Vyse A.J., Enquselassie F., Nigatu W., and Nokes D.J. improving sensitivity of oral fluid testing in IgG prevalence studies: application of mixture models to a rubella antibody survey. Epidemiol Infect 130 2 (2003) 285-291
9. Gay N.J. Analyses of serological surveys using mixture models: application to a survey of Parvovirus B19. Stat Med 15 (1996) 1567-1573
10. Ciofi degli Atti M.L., Salmaso S., Bella A., Arigliani R., Gangemi M., Brusoni G., et al. Paediatric sentinel surveillance of vaccine-preventable diseases in Italy. Pediatr Infect Dis J 21 (2002) 763-768
11. Ministero della Sanità. Decreto 7 aprile 1999. Nuovo calendario delle vaccinazioni obbligatorie e raccomandate per l'età evolutiva. G.U. n. 87 del 15 aprile 1999.
12. Salmaso S., Rota M.C., Ciofi degli Atti M.L., Tozzi A.E., Kreidl P., and The ICONA Study Group. Infant immunization coverage in Italy: estimates by simultaneous EPI cluster surveys of regions. Bull World Health Organ 77 10 (1999) 843-851
13. http://www.ministerosalute.it/promozione/malattie/documenti/CopVaccPED2004new.pdf [accessed 15 February 2008].
14. Gabutti G., Rota M.C., Salmaso S., Bruzzone B.M., Bella A., Crovari P., et al. Epidemiology of measles, mumps and rubella in Italy. Epidemiol Infect 129 (2002) 543-550
15. StataCorp. Stata statistical software: release 9 (2005), Stata Corp LP, College Station, TX
16. Efron B., and Tibshirani R.J. An introduction to the bootstrap (1993), Chapman and Hall, New York
17. R Development Core Team. R: A language and environment for statistical computing (2006), R Foundation for Statistical Computing, Vienna, Austria. 3-900051-070. http://www.R-project.org
18. Peter Macdonald, Juan Du, 2004. Mixdist: mixture distribution models. R package version 0.5-1. http://www.math.mcmaster.ca/peter/mix/mix.html.
19. Kremer J.R., Schneider F., and Muller C.P. Waning antibodies in measles and rubella vaccines-a longitudinal study. Vaccine (2006) 2594-2601
20. Guris D., Mc Cready J., Watson J.C., Atkinson W.L., Heath J.L., Bellini W.J., et al. Measles vaccine effectiveness and duration of vaccine-induced immunity in the absence of boosting from exposure to measles virus. Pediatr Infect Dis J 15 12 (1996) 1082-1086
21. Parker R.A., Erdman D.D., and Anderson L.J. Use of mixture models in determining laboratory criterion for identification of seropositive individuals: application to parvovirus B19 serology. J Virol Methods 27 2 (1990) 135-144
22. Vyse A.J., Gay N.J., Hesketh L.M., Pebody R., Morgan-Capner P., and Miller E. Seroprevalence of antibody to varicella zoster virus in England and Wales in children and young adults. Epidemiol Infect 132 6 (2004) 1129-1134
23. van den Hof S., Berbers G.A.M., de Melker H.E., and Conyn-van Spaendonck M.A.E. Sero-epidemiology of measles antibodies in the Netherlands, a cross-sectional study in a national sample and in communities with low vaccine coverage. Vaccine 18 (1999) 931-940
24. Ciofi degli Atti M, Filia A, Nicoletti L, Ferro A, Franco E, Grilli G, et al. Studio di avanzamento del piano nazionale di eliminazione del morbillo e della rosolia. BEN 2007; 20 (3). Available from: http://www.epicentro.iss.it/ben/2007/marzo/1.asp.